Clinical trials can provide patients with myeloproliferative neoplasms expanded treatment options.
Kathryn Johnson, DNP, MSc, FNP-BC
Advertisement
Articles by Kathryn Johnson, DNP, MSc, FNP-BC
Advertisement
Latest Updated Articles
Clinical Trials Can Open Doors for Patients With Myeloproliferative NeoplasmsPublished: April 23rd 2025 | Updated:
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Greenlights Niraparib/Abiraterone Acetate With Prednisone in mHSPC
2
Progression Occurs Early in R/R LBCL Treated With Epcoritamab, Glofitamab
3
Oral Azacitidine Yields Similar PK to Subcutaneous Azacitidine in MDS/CMML
4
Sacituzumab Govitecan Fails to Reach Significant PFS in HR+/HER2– mBC
5
